T
45
-2
DOW
36
-2
ALL
37
-3
AA
29
-5
MCD
57
-5
ALLE
35
-2
CMI
58
-2
LH
36
-3
JNJ
35
-6
GPC
37
-3
KMB
30
-3
CTSH
56
4
SHW
53
-2
HCA
44
-2
MCK
52
-3
RF
48
-3
VZ
37
-2
NRG
40
3
CSCO
61
-3
XEL
53
-2
T
45
-2
DOW
36
-2
ALL
37
-3
AA
29
-5
MCD
57
-5
ALLE
35
-2
CMI
58
-2
LH
36
-3
JNJ
35
-6
GPC
37
-3
KMB
30
-3
CTSH
56
4
SHW
53
-2
HCA
44
-2
MCK
52
-3
RF
48
-3
VZ
37
-2
NRG
40
3
CSCO
61
-3
XEL
53
-2
Financhill
Back

Nuveen Real Asset Income and Growth Fund Vs. Aligos Therapeutics Industry Stock Comparison

Sell
50

JRI
Nuveen Real Asset Income and Growth Fund

Last Price:
13.20
Seasonality Move:
0.37%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
35.13
Seasonality Move:
10.65%
Sell
50
Nuveen Real Asset Income and Growth Fund (JRI) is a Sell

Is Nuveen Real Asset Income and Growth Fund a Buy, Sell or Hold?

  • The current Nuveen Real Asset Income and Growth Fund [JRI] share price is $13.30. The Score for JRI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • JRI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

JRI Stock Price Chart

What is Nuveen Real Asset Income and Growth Fund's stock price today?

  • The Nuveen Real Asset Income and Growth Fund share price today is $13.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JRI is experiencing slight selling pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

JRI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 48.26 Sell
Chaikin Money Flow: -21344 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.21 - 13.49) Sell
Bollinger Bands (100): (12.75 - 13.41) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

JRI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.44 Sell
20-day SMA: 13.34 Sell
50-day SMA: 13.25 Buy
200-day SMA: 12.39 Buy
8-day EMA: 13.39 Sell
20-day EMA: 13.36 Sell
50-day EMA: 13.26 Buy
200-day EMA: 12.6 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

Nuveen Real Asset Income and Growth Fund Earnings Growth & JRI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Nuveen Real Asset Income and Growth Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):